Jefferies Financial Group reissued their sell rating on shares of Reckitt Benckiser Group (LON:RB) in a research note released on Friday morning, Borsen Zeitung reports. They currently have a GBX 5,000 ($65.33) target price on the stock.

Several other brokerages have also recently weighed in on RB. Liberum Capital reissued a buy rating and set a GBX 7,300 ($95.39) price target on shares of Reckitt Benckiser Group in a research report on Thursday, October 31st. Shore Capital reissued an under review rating on shares of Reckitt Benckiser Group in a research report on Tuesday, October 22nd. Societe Generale set a GBX 5,700 ($74.48) price target on shares of Reckitt Benckiser Group and gave the company a sell rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. reissued an overweight rating on shares of Reckitt Benckiser Group in a research report on Monday, November 4th. Finally, Barclays lowered their price target on shares of Reckitt Benckiser Group from GBX 7,500 ($98.00) to GBX 6,700 ($87.55) and set an overweight rating on the stock in a research report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, four have given a hold rating and ten have given a buy rating to the company. Reckitt Benckiser Group presently has a consensus rating of Hold and a consensus target price of GBX 6,773.33 ($88.51).

Shares of RB stock traded up GBX 8 ($0.10) on Friday, hitting GBX 5,923 ($77.39). 753,399 shares of the stock traded hands, compared to its average volume of 1,720,000. The firm’s 50-day moving average price is GBX 5,996.28 and its two-hundred day moving average price is GBX 6,236.26. The company has a debt-to-equity ratio of 85.08, a quick ratio of 0.43 and a current ratio of 0.59. The stock has a market capitalization of $41.96 billion and a PE ratio of 29.73. Reckitt Benckiser Group has a twelve month low of GBX 5,510 ($72.00) and a twelve month high of GBX 6,778 ($88.57).

In other Reckitt Benckiser Group news, insider Warren Tucker purchased 580 shares of the business’s stock in a transaction on Friday, October 25th. The shares were bought at an average cost of GBX 5,810 ($75.92) per share, for a total transaction of £33,698 ($44,032.41). Also, insider Adrian Nevil Hennah sold 81,063 shares of the business’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of GBX 6,399 ($83.61), for a total transaction of £5,187,221.37 ($6,778,023.48).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Read More: What is a Real Estate Investment Trust (REIT)?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.